Screener
Citius Oncology, Inc. CTOR Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $16.56M+14,788,922% | $2.63M+2,350,466% | $7.3M+6,513,696% | $3.92M+3,504,282% | $112-57.1% | ||
| $686.24K— | $1.08M— | $4.05M— | —— | —— | ||
| $22.63M+31.5% | $22.66M+47.7% | $22.64M+57.4% | $22.29M+170% | $17.21M+3,126% | ||
| $42.71M+133% | $29.42M+63.1% | $37.15M+117% | $27.54M+151% | $18.31M+44,569% | ||
| $112.09M+22.2% | $100.7M+10.1% | $109.97M+21.5% | $100.94M+19.6% | $91.71M+86.4% | ||
| $7.32M-15.6% | $8.88M+15.7% | $10.45M+77.8% | $13.23M+257% | $8.67M— | ||
| $58.79M+10.9% | $58.81M+18.2% | $44.71M+3.0% | $49.49M+51.3% | $52.99M+1,620% | ||
| $10M— | —— | —— | —— | —— | ||
| $71.71M+20.9% | $65.43M+17.3% | $51.56M+4.8% | $56.08M+46.7% | $59.31M— | ||
| 400M0.0% | 400M+300% | 400M+300% | 400M+264% | 400M+167% | ||
| -$105.11M-78.0% | -$96.18M-79.2% | -$69.57M-51.5% | -$64.04M-63.0% | -$59.04M-1,842% | ||
| $40.38M+24.7% | $35.27M-1.0% | $58.41M+41.5% | $44.87M-2.8% | $32.4M+90.2% | ||
| $112.09M+22.2% | $100.7M+10.1% | $109.97M+21.5% | $100.94M+19.6% | $91.71M+86.4% |
FAQ
- What are Citius Oncology, Inc.'s total assets?
- Citius Oncology, Inc. (CTOR) holds $112.1M in total assets, up 22.2% year over year.
- How much debt does Citius Oncology, Inc. have?
- Citius Oncology, Inc. carries $16.4M in total debt against $40.4M of shareholders' equity, a debt-to-equity ratio of 0.41.
- How much cash does Citius Oncology, Inc. have?
- Citius Oncology, Inc. holds $16.6M in cash and equivalents.
- Can Citius Oncology, Inc. cover its short-term obligations?
- Its current ratio is 0.73 — current liabilities exceed current assets.
- Where does Citius Oncology, Inc.'s balance sheet data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.